Yiqibushen Jieduhuoxue Side Joint Observation Of The Efficacy Of Chemotherapy In The Treatment Of Multiple Myeloma,

Purpose: To observe the efficacy of Prescription of YiQi HuoXue and BuShen JieDu combined with VAD chemotherapy for multiple myeloma。Method:The 38 cases of multiple myeloma patients were randomly divided into two groups: treatment group with 20 cases of add kidney Qi, activating blood detoxification the joint VAD chemotherapy in the control group 18 cases with conventional chemotherapy in the treatment of VAD,Two groups of treatment time were 70 days. Observed and compared the two groups in pain and other symptoms of peripheral blood, bone marrow and other physical and chemical inspection and overall differences in efficacyResults:1. Qi Huo Xue Fang kidney detoxification combined with chemotherapy group than in the control group improved more in patients with pain symptoms, and treatment group of the traditional Chinese medicine can improve the patient's disease Hou.2. The treatment group so that cell counts in patients with decreased osteoclasts, osteogenic cell count was significantly higher, although osteoblasts compared with the control group after treatment, no statistically significant difference (P> 0.05), but the osteoclasts after treatment difference between the two groups was statistically significant (P <0.05), the treatment group improved more than the control group of patients with plasma cell ratio, M protein level indicators; In addition, the combination therapy group treatment of multiple myeloma the inhibition of hematopoietic system Western VAD chemotherapy than simply a small, but after treatment, erythrocyte sedimentation rate, serum calcium, blood urea nitrogen decreased compared with before treatment, the difference was statistically significant (P <0.05), which the two groups after treatment in normal serum calcium value of more than range.3. Overall efficacy in the treatment group of TCM symptoms more pronounced effect than the control group, the clinical efficacy of Western medicine treatment group better than the control group, treatment group, the total effective rate as high as 65%, adverse reactions significantly lower than the control group. Conclusion:Joint of the VAD chemotherapy Yiqibushen Jieduhuoxue prescription of Chinese medicine can "synergistic" effect with chemotherapy, but also reduce the side effects of chemotherapy, so that chemotherapy can proceed smoothly. In short, combining Chinese and Western methods to Yiqibushen Jieduhuoxue side with the VAD regimen in the treatment of multiple myeloma to relieve symptoms and reduce the suffering of patients and improve their quality of life, improve the clinical efficacy, so France is worthy of clinical application.